Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000342841 | SCV001397550 | benign | Glanzmann thrombasthenia | 2019-07-19 | reviewed by expert panel | curation | The c.891+12del intronic variant has not been reported in the literature, to our knowledge. It is present in an African control population at an allele frequency of 0.01490 and no splice impact is predicted. In summary, this variant meets criteria to be classified as benign for GT. GT-specific criteria applied: BA1, BP7. |
Illumina Laboratory Services, |
RCV000342841 | SCV000403382 | uncertain significance | Glanzmann thrombasthenia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502253 | SCV002804395 | likely benign | Platelet-type bleeding disorder 16; Glanzmann thrombasthenia 1 | 2021-12-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000342841 | SCV003508723 | benign | Glanzmann thrombasthenia | 2024-01-19 | criteria provided, single submitter | clinical testing |